Recruiting NA Schizophrenia

New treatment option for Schizophrenia

Official title App and Body Fat Scale in the Management of Overweight Patients

ClinicalTrials.gov ID: NCT05866107

What this study is testing

What it's testing
This study tests whether using a health app (Huawei Health) and a smart body fat scale can help overweight patients with schizophrenia or bipolar disorder lose weight and stay engaged in their health. What We're Testing: 1.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 60

You may be able to join if

  • Age 18-60 years old, no gender restriction.
  • According to ICD-10 to diagnose bipolar disorder or schizophrenia, the researcher judges that the patient is currently in remission, or the condition...
  • Currently using at least one antipsychotic or mood stabilizer (e.g. lithium, magnesium valproate, sodium valproate, lamotrigine).
  • Currently overweight or obese (body mass index ≥ 24kg/m2) and willing to use health app and smart scales to lose weight.
  • The education level of primary school or above, able to understand the content of the scale, and be able to use smart phone proficiently.

You likely can't join if

  • Plan to lose weight by other methods during the study period (such as dieting, inducing vomiting, taking diet pills, surgery).
  • Self-reported weight loss ≥ 7% in the past 6 months.
  • Weight over 150 kg.
  • Other secondary obesity (such as hypothyroidism, Cushing's syndrome, hypothalamic obesity, etc.).
  • Currently pregnant, lactating, \< 6 months postpartum or planning to become pregnant during the study period.
  • Self-reported cardiac discomfort or chest pain during activity or at rest.
See the full eligibility criteria
Who can join
  • Age 18-60 years old, no gender restriction.
  • According to ICD-10 to diagnose bipolar disorder or schizophrenia, the researcher judges that the patient is currently in remission, or the condition is stable and can cooperate with the research.
  • Currently using at least one antipsychotic or mood stabilizer (e.g. lithium, magnesium valproate, sodium valproate, lamotrigine).
  • Currently overweight or obese (body mass index ≥ 24kg/m2) and willing to use health app and smart scales to lose weight.
  • The education level of primary school or above, able to understand the content of the scale, and be able to use smart phone proficiently.
  • Understand and voluntarily participate in this study, and sign the informed consent form.
What rules you out
  • Plan to lose weight by other methods during the study period (such as dieting, inducing vomiting, taking diet pills, surgery).
  • Self-reported weight loss ≥ 7% in the past 6 months.
  • Weight over 150 kg.
  • Other secondary obesity (such as hypothyroidism, Cushing's syndrome, hypothalamic obesity, etc.).
  • Currently pregnant, lactating, \< 6 months postpartum or planning to become pregnant during the study period.
  • Self-reported cardiac discomfort or chest pain during activity or at rest.
  • There is a serious medical condition, and the researchers believe that there may be safety risks when participating in sports.
  • Be unable to walk 30 minutes without stopping.
  • There are problems that may affect compliance with the protocol (eg, end-stage disease, planning to move travel to the field, history of substance abuse, other uncontrolled or untreated medical conditions);
  • Any other conditions deemed inappropriate by the investigator. Participants include approximately 50% with schizophrenia and 50% with bipolar disorder, distributed across all clusters.

The study team makes the final eligibility decision.

Where it's taking place

  • Beijing, Beijing Municipality, China

Compensation & support

Compensation mentioned.

ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.

Questions & answers

Do participants get paid in this trial?

This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 60 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Beijing, Beijing Municipality, China. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.